{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:34:40Z","timestamp":1784068480315,"version":"3.55.0"},"reference-count":191,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Arenaviruses belonging to the Arenaviridae family, genus mammarenavirus, are enveloped, single-stranded RNA viruses primarily found in rodent species, that cause severe hemorrhagic fever in humans. With high mortality rates and limited treatment options, the search for effective antivirals is imperative. Current treatments, notably ribavirin and other nucleoside inhibitors, are only partially effective and have significant side effects. The high lethality and lack of treatment, coupled with the absence of vaccines for all but Jun\u00edn virus, has led to the classification of these viruses as Category A pathogens by the Centers for Disease Control (CDC). This review focuses on entry inhibitors as potential therapeutics against mammarenaviruses, which include both New World and Old World arenaviruses. Various entry inhibition strategies, including small molecule inhibitors and neutralizing antibodies, have been explored through high throughput screening, genome-wide studies, and drug repurposing. Notable progress has been made in identifying molecules that target receptor binding, internalization, or fusion steps. Despite promising preclinical results, the translation of entry inhibitors to approved human therapeutics has faced challenges. Many have only been tested in <jats:italic>in vitro<\/jats:italic> or animal models, and a number of candidates showed efficacy only against specific arenaviruses, limiting their broader applicability. The widespread existence of arenaviruses in various rodent species and their potential for their zoonotic transmission also underscores the need for rapid development and deployment of successful pan-arenavirus therapeutics. The diverse pool of candidate molecules in the pipeline provides hope for the eventual discovery of a broadly effective arenavirus antiviral.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1382953","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:52:31Z","timestamp":1712551951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Entry inhibitors as arenavirus antivirals"],"prefix":"10.3389","volume":"15","author":[{"given":"Kruthika","family":"Iyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/NSMB.1772","article-title":"Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses","volume":"17","author":"Abraham","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1128\/jvi.02779-06","article-title":"Bitopic membrane topology of the stable signal peptide in the tripartite Jun\u00edn virus GP-C envelope glycoprotein complex","volume":"81","author":"Agnihothram","year":"2007","journal-title":"J. Virol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"11789","DOI":"10.1016\/s0021-9258(19)49767-6","article-title":"High affinity inhibition of Ca2+-dependent K+ channels by cytochrome P-450 inhibitors","volume":"267","author":"Alvarez","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e01741-19","DOI":"10.1128\/JVI.01741-19","article-title":"Monoclonal antibodies with neutralizing activity and fc-effector functions against the Machupo virus glycoprotein","volume":"94","author":"Amanat","year":"2020","journal-title":"J. Virol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1128\/AAC.00951-22","article-title":"Safety and pharmacokinetics of LHF-535, a potential treatment for Lassa fever, in healthy adults","volume":"66","author":"Amberg","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4161\/hv.7.6.15198","article-title":"Argentine hemorrhagic fever vaccines","volume":"7","author":"Ambrosio","year":"2011","journal-title":"Hum. Vaccin."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/GUTJNL-2012-304299","article-title":"Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells","volume":"63","author":"Anggakusuma","year":"2014","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.3390\/MOLECULES26226994","article-title":"Antiviral therapeutic potential of curcumin: an update","volume":"26","author":"Ardebili","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1182\/BLOOD-2007-08-110098","article-title":"Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia","volume":"111","author":"Ataga","year":"2008","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.172.5.2861","article-title":"Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells","volume":"172","author":"Baize","year":"2004","journal-title":"J. Immunol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected Cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J. Virol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1128\/JVI.77.5.2866-2872.2003","article-title":"Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1\/S1P","volume":"77","author":"Beyer","year":"2003","journal-title":"J. Virol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1158\/1078-0432.CCR-12-3247","article-title":"EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-met inhibitors","volume":"19","author":"Bladt","year":"2013","journal-title":"Clin. Cancer. Res."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/J.ANTIVIRAL.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: an update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antivir. Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/J.ANTIVIRAL.2005.10.008","article-title":"Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses","volume":"69","author":"Bolken","year":"2006","journal-title":"Antivir. Res."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/VIRO.1996.0248","article-title":"The phylogeny of New World (Tacaribe complex) arenaviruses","volume":"219","author":"Bowen","year":"1996","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","article-title":"Genetic diversity among Lassa virus strains","volume":"74","author":"Bowen","year":"2000","journal-title":"J. Virol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/NRD984","article-title":"Therapeutic antibodies for human diseases at the dawn of the twenty-first century","volume":"2","author":"Brekke","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/J.MOLCEL.2010.10.005","article-title":"Membranes in balance: mechanisms of sphingolipid homeostasis","volume":"40","author":"Breslow","year":"2010","journal-title":"Mol. Cell"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0127822","DOI":"10.1128\/MBIO.01278-22","article-title":"Neutralizing antibodies against Lassa virus lineage I","volume":"13","author":"Buck","year":"2022","journal-title":"MBio"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/J.BMCL.2012.11.093","article-title":"Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocycles","volume":"23","author":"Burgeson","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3390\/V4102162","article-title":"Envelope glycoprotein of arenaviruses","volume":"4","author":"Burri","year":"2012","journal-title":"Viruses"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/J.CHEMBIOL.2013.05.010","article-title":"PIKfyve, a class III PI kinase, is the target of the small molecular IL-12\/IL-23 inhibitor apilimod and a player in toll-like receptor signaling","volume":"20","author":"Cai","year":"2013","journal-title":"Chem. Biol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/S12250-020-00305-3\/FIGURES\/1","article-title":"Griffithsin with A broad-Spectrum antiviral activity by binding Glycans in viral glycoprotein exhibits strong synergistic effect in combination with A Pan-coronavirus fusion inhibitor targeting SARS-CoV-2 spike S2 subunit","volume":"35","author":"Cai","year":"2020","journal-title":"Virol. Sin."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3201\/EID1803.111602","article-title":"Ocozocoautla de Espinosa Virus and Hemorrhagic Fever, Mexico","volume":"18","author":"Cajimat","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1002\/J.1460-2075.1989.TB08544.X","article-title":"Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3\u2019 untranslated region of the mRNA","volume":"8","author":"Casey","year":"1989","journal-title":"EMBO J."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/J.ANTIVIRAL.2011.02.012","article-title":"Evaluation of Lassa antiviral compound ST-193 in a guinea pig model","volume":"90","author":"Cashman","year":"2011","journal-title":"Antivir. Res."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-23760-2","article-title":"Lassa antiviral LHF-535 protects guinea pigs from lethal challenge","volume":"12","author":"Cashman","year":"2022","journal-title":"Sci. Rep."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/S11745-009-3305-7","article-title":"Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes","volume":"44","author":"Cenedella","year":"2009","journal-title":"Lipids"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/J.ANTIVIRAL.2011.02.009","article-title":"Arenaviruses and hantaviruses: from epidemiology and genomics to antivirals","volume":"90","author":"Charrel","year":"2011","journal-title":"Antivir. Res."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/J.VETMIC.2009.08.027","article-title":"Zoonotic aspects of arenavirus infections","volume":"140","author":"Charrel","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/MOLECULES28041579","article-title":"Design, synthesis, and biological evaluation of Benzimidazole derivatives as potential Lassa virus inhibitors","volume":"28","author":"Chen","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/448645A","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1128\/JVI.00103-16","article-title":"Identification and characterization of a novel broad-Spectrum virus entry inhibitor","volume":"90","author":"Chou","year":"2016","journal-title":"J. Virol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1586\/14737159.8.2.179","article-title":"KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?","volume":"8","author":"Chou","year":"2008","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/S41467-019-13924-6","article-title":"Rational design of universal immunotherapy for TfR1-tropic arenaviruses","volume":"11","author":"Cohen-Dvashi","year":"2020","journal-title":"Nat. Commun."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"10329","DOI":"10.1128\/JVI.01624-16","article-title":"Role of LAMP1 binding and pH sensing by the spike complex of Lassa virus","volume":"90","author":"Cohen-Dvashi","year":"2016","journal-title":"J. Virol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"9415","DOI":"10.1128\/JVI.75.19.9415-9426.2001","article-title":"RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome","volume":"75","author":"Cornu","year":"2001","journal-title":"J. Virol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1128\/JVI.01711-08","article-title":"Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles","volume":"83","author":"Cosset","year":"2009","journal-title":"J. Virol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/J.COVIRO.2019.07.003","article-title":"Antibody therapy for Lassa fever","volume":"37","author":"Cross","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/J.BMCL.2012.11.095","article-title":"Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole","volume":"23","author":"Dai","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"640","DOI":"10.4269\/AJTMH.1963.12.640","article-title":"Tacaribe virus, a new agent isolated from Artibeus bats and mosquitoes in Trinidad, West Indies","volume":"12","author":"Downs","year":"1963","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/JOF6040324","article-title":"Isavuconazole: mechanism of action, clinical efficacy, and resistance","volume":"6","author":"Ellsworth","year":"2020","journal-title":"J. Fungi (Basel, Switzerland)"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/J.ANTIVIRAL.2007.10.010","article-title":"Treatment of argentine hemorrhagic fever","volume":"78","author":"Enria","year":"2008","journal-title":"Antivir. Res."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"110841","DOI":"10.1016\/J.CELREP.2022.110841","article-title":"Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies","volume":"39","author":"Enriquez","year":"2022","journal-title":"Cell Rep."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/17460441.2012.687719.Drug","article-title":"Genetic changes NIH public access","volume":"23","author":"Eunsung Mouradian","year":"2008","journal-title":"Bone"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/J.JMB.2018.04.026","article-title":"Novel insights into cell entry of emerging human pathogenic arenaviruses","volume":"430","author":"Fedeli","year":"","journal-title":"J. Mol. Biol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/V12080857","article-title":"The role of receptor tyrosine kinases in Lassa virus cell entry","volume":"12","author":"Fedeli","year":"2020","journal-title":"Viruses"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e01613-17","DOI":"10.1128\/JVI.01613-17","article-title":"Axl can serve as entry factor for Lassa virus depending on the functional glycosylation of Dystroglycan","volume":"92","author":"Fedeli","year":"","journal-title":"J. Virol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/V4112973","article-title":"Multifunctional nature of the arenavirus RING finger protein Z","volume":"4","author":"Fehling","year":"2012","journal-title":"Viruses"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1126\/SCIENCE.1066371","article-title":"Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR","volume":"294","author":"Feinberg","year":"2001","journal-title":"Science (New York, N.Y.)"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/jvi.70.4.2208-2214.1996","article-title":"Filovirus-induced endothelial leakage triggered by infected monocytes\/macrophages","volume":"70","author":"Feldmann","year":"1996","journal-title":"J. Virol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0216321","DOI":"10.1128\/jvi.02163-21","article-title":"Correction for Ferrero et al., \u201cantibody-based inhibition of pathogenic New World hemorrhagic fever Mammarenaviruses by steric occlusion of the human transferrin receptor 1 apical domain.\u201d","volume":"96","author":"Ferrero","year":"2022","journal-title":"J. Virol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/VIRO.1996.0512","article-title":"Isolation and characterization of whitewater arroyo virus, a novel north American arenavirus","volume":"224","author":"Fulhorst","year":"1996","journal-title":"Virology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/S41579-022-00789-8","article-title":"Lassa fever \u2013 the road ahead","volume":"21","author":"Garry","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: Progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/J.MICINF.2010.12.006","article-title":"Jun\u00edn virus. A XXI century update","volume":"13","author":"G\u00f3mez","year":"2011","journal-title":"Microbes Infect."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"11504","DOI":"10.1128\/JVI.01893-13","article-title":"Role of DC-SIGN in Lassa virus entry into human dendritic cells","volume":"87","author":"Goncalves","year":"2013","journal-title":"J. Virol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"105125","DOI":"10.1016\/J.ANTIVIRAL.2021.105125","article-title":"Potent inhibition of arenavirus infection by a novel fusion inhibitor","volume":"193","author":"Gowen","year":"2021","journal-title":"Antivir. Res."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/82_2015_468","article-title":"Arenavirus Quasispecies and their biological implications","volume":"392","author":"Grande-P\u00e9rez","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3201\/EID2712.211088","article-title":"Mammarenaviruses of rodents, South Africa and Zimbabwe","volume":"27","author":"Grobbelaar","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/ANNUREV.CB.10.110194.000335","article-title":"Small GTP-binding proteins and the regulation of the actin cytoskeleton","volume":"10","author":"Hall","year":"1994","journal-title":"Annu. Rev. Cell Biol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3389\/FMICB.2018.01751","article-title":"Review of Mammarenavirus biology and replication","volume":"9","author":"Hallam","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/J.CELL.2019.07.020","article-title":"Convergent structures illuminate features for germline antibody binding and Pan-Lassa virus neutralization","volume":"178","author":"Hastie","year":"2019","journal-title":"Cell"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/SCIENCE.AAM7260","article-title":"Structural basis for antibody-mediated neutralization of Lassa virus","volume":"356","author":"Hastie","year":"2017","journal-title":"Science (New York, N.Y.)"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1128\/JVI.06397-11","article-title":"An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic fever arenaviruses","volume":"86","author":"Helguera","year":"2012","journal-title":"J. Virol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"e01146-20","DOI":"10.1128\/AAC.01146-20","article-title":"Inhibition of arenaviruses by combinations of orally available approved drugs","volume":"65","author":"Herring","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/S41467-021-27949-3","article-title":"Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections","volume":"13","author":"Hickerson","year":"2022","journal-title":"Nat. Commun."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/ELIFE.55352","article-title":"Type I interferon underlies severe disease associated with Jun\u00edn virus infection in mice","volume":"9","author":"Hickerson","year":"2020","journal-title":"eLife"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","article-title":"R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer","volume":"70","author":"Holland","year":"2010","journal-title":"Cancer Res."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/V14122649","article-title":"Screening and identification of Lassa virus entry inhibitors from a fragment-based drug discovery library","volume":"14","author":"Hou","year":"2022","journal-title":"Viruses"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"e1659","DOI":"10.1371\/journal.pntd.0001659","article-title":"Jun\u00edn virus infection activates the type I interferon pathway in a RIG-I-dependent manner","volume":"6","author":"Huang","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1128\/jvi.00526-15","article-title":"Highly pathogenic New World and Old World human arenaviruses induce distinct interferon responses in human cells","volume":"89","author":"Huang","year":"2015","journal-title":"J. Virol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e01818-17","DOI":"10.1128\/MBIO.01818-17","article-title":"Lamp1 increases the efficiency of Lassa virus infection by promoting fusion in less acidic endosomal compartments","volume":"9","author":"Hulseberg","year":"2018","journal-title":"MBio"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"e02185-18","DOI":"10.1128\/JVI.02185-18","article-title":"Arbidol and other low-molecular-weight drugs that inhibit Lassa and Ebola viruses","volume":"93","author":"Hulseberg","year":"2019","journal-title":"J. Virol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1073\/PNAS.94.21.11651","article-title":"A human intermediate conductance calcium-activated potassium channel","volume":"94","author":"Ishii","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1128\/JVI.02110-13","article-title":"Sodium hydrogen exchangers contribute to arenavirus cell entry","volume":"88","author":"Iwasaki","year":"2014","journal-title":"J. Virol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/J.TIM.2015.04.006","article-title":"Emerging intracellular receptors for hemorrhagic fever viruses","volume":"23","author":"Jae","year":"2015","journal-title":"Trends Microbiol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1126\/SCIENCE.1252480","article-title":"Virus entry. Lassa virus entry requires a trigger-induced receptor switch","volume":"344","author":"Jae","year":"2014","journal-title":"Science (New York, N.Y.)"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3390\/V12111242","article-title":"Curcumin as an antiviral agent","volume":"12","author":"Jennings","year":"2020","journal-title":"Viruses"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1073\/PNAS.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1038\/S41467-021-24458-1","article-title":"Structural basis for recognition and regulation of arenavirus polymerase L by Z protein","volume":"12","author":"Kang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1099\/VIR.0.82950-0","article-title":"Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity","volume":"88","author":"Klewitz","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e1009356","DOI":"10.1371\/JOURNAL.PPAT.1009356","article-title":"Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity","volume":"17","author":"Koma","year":"2021","journal-title":"PLoS Pathog."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"19743","DOI":"10.1073\/PNAS.1112742108\/-\/DCSUPPLEMENTAL\/PNAS.201112742SI.PDF","article-title":"Arenavirus Z protein controls viral RNA synthesis by locking a polymerase-promoter complex","volume":"108","author":"Kranzusch","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e30051","DOI":"10.1371\/JOURNAL.PONE.0030051","article-title":"Activation mobilizes the cholesterol in the late endosomes-lysosomes of Niemann pick type C cells","volume":"7","author":"Lange","year":"2012","journal-title":"PLoS One"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"10768","DOI":"10.1128\/jvi.00941-08","article-title":"Identification of a broad-Spectrum arenavirus entry inhibitor","volume":"82","author":"Larson","year":"2008","journal-title":"J. Virol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"204ra131","DOI":"10.1126\/SCITRANSLMED.3006827","article-title":"siRNA screen for genes that affect Jun\u00edn virus entry uncovers voltage-gated calcium channels as a therapeutic target","volume":"5","author":"Lavanya","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.virol.2010.11.022","article-title":"Novel approaches in anti-arenaviral drug development","volume":"411","author":"Lee","year":"2011","journal-title":"Virology"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"18734","DOI":"10.1074\/jbc.M802089200","article-title":"Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"12701","DOI":"10.1073\/PNAS.221447598","article-title":"The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P","volume":"98","author":"Lenz","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/INFDIS\/149.3.428","article-title":"Endogenous interferon in argentine hemorrhagic fever","volume":"149","author":"Levis","year":"1984","journal-title":"J. Infect. Dis."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/JIR.1985.5.383","article-title":"Correlation between endogenous interferon and the clinical evolution of patients with argentine hemorrhagic fever","volume":"5","author":"Levis","year":"1985","journal-title":"J. Interf. Res."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"eabq0991","DOI":"10.1126\/SCITRANSLMED.ABQ0991","article-title":"A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus","volume":"14","author":"Li","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/J.VIROL.2014.11.026","article-title":"Isolation and characterization of a novel arenavirus harbored by rodents and shrews in Zhejiang province, China","volume":"476","author":"Li","year":"2015","journal-title":"Virology"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e21635","DOI":"10.7554\/ELIFE.21635","article-title":"Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export","volume":"5","author":"Li","year":"2016","journal-title":"eLife"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"e02429-20","DOI":"10.1128\/JVI.02429-20","article-title":"Screening of botanical drugs against Lassa virus entry","volume":"95","author":"Liu","year":"2021","journal-title":"J. Virol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"e0020522","DOI":"10.1128\/mbio.00205-22","article-title":"Genome-wide knockout screen identifies human Sialomucin CD164 as an essential entry factor for lymphocytic Choriomeningitis virus","volume":"13","author":"Liu","year":"2022","journal-title":"MBio"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"104619","DOI":"10.1016\/J.BIOORG.2020.104619","article-title":"Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses","volume":"107","author":"Lu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"116282","DOI":"10.1038\/s41392-020-00315-3","article-title":"Recent advances in the development of protein\u2013protein interactions modulators: mechanisms and clinical trials. Signal transduction and targeted","volume":"5","author":"Lu","year":"2020","journal-title":"Therapy"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/V8100296","article-title":"Griffithsin: an antiviral lectin with outstanding therapeutic potential","volume":"8","author":"Lusvarghi","year":"2016","journal-title":"Viruses"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"e1007439","DOI":"10.1371\/JOURNAL.PPAT.1007439","article-title":"A potent Lassa virus antiviral targets an arenavirus virulence determinant","volume":"14","author":"Madu","year":"2018","journal-title":"PLoS Pathog."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1086\/320722","article-title":"Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever","volume":"183","author":"Mahanty","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0140-6736(79)92335-3","article-title":"Efficacy of immune plasma in treatment of argentine haemorrhagic fever and association between treatment and a late neurological syndrome","volume":"2","author":"Maiztegui","year":"1979","journal-title":"Lancet (London, England)"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3389\/FMICB.2015.01037","article-title":"Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage","volume":"6","author":"Manning","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/VACCINES7040138","article-title":"Differential immune responses to hemorrhagic fever-causing arenaviruses","volume":"7","author":"Mantlo","year":"2019","journal-title":"Vaccine"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/S40265-020-01452-3","article-title":"REGN-EB3: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/J.BBRC.2013.10.106","article-title":"Utilization of human DC-SIGN and L-SIGN for entry and infection of host cells by the New World arenavirus, Jun\u00edn virus","volume":"441","author":"Martinez","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1099\/VIR.0.82808-0","article-title":"Characterization of Junin arenavirus cell entry","volume":"88","author":"Martinez","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/BIOT.200800357","article-title":"Involvement of cellular proteins in Junin arenavirus entry","volume":"4","author":"Martinez","year":"2009","journal-title":"Biotechnol. J."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/V13040685","article-title":"Identification of novel antiviral compounds targeting entry of hantaviruses","volume":"13","author":"Mayor","year":"2021","journal-title":"Viruses"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ncb0509-510","article-title":"Virus entry by macropinocytosis","volume":"11","author":"Mercer","year":"2009","journal-title":"Nat. Cell. Bio."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1128\/JVI.00136-12","article-title":"Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection","volume":"86","author":"Miller","year":"2012","journal-title":"J. Virol."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/NM.4396","article-title":"Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever","volume":"23","author":"Mire","year":"2017","journal-title":"Nat. Med."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"28939","DOI":"10.1074\/JBC.M104565200","article-title":"A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands","volume":"276","author":"Mitchell","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/J.CHEMBIOL.2023.03.005","article-title":"Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virus","volume":"30","author":"Moon-Walker","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"7246","DOI":"10.1128\/jvi.00614-11","article-title":"Ribavirin can be mutagenic for arenaviruses","volume":"85","author":"Moreno","year":"2011","journal-title":"J. Virol."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"e1001121","DOI":"10.1371\/JOURNAL.PPAT.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"e0005540","DOI":"10.1371\/JOURNAL.PNTD.0005540","article-title":"The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection","volume":"11","author":"Nelson","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/BLOOD-2006-04-020263","article-title":"Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor","volume":"108","author":"Ng","year":"2006","journal-title":"Blood"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"e0265021","DOI":"10.1128\/MBIO.02650-21","article-title":"Contrasting modes of New World arenavirus neutralization by immunization-elicited monoclonal antibodies","volume":"13","author":"Ng","year":"2022","journal-title":"MBio"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1517\/13543784.2015.1006358","article-title":"Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease","volume":"24","author":"Norman","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/V4010083","article-title":"The curious case of arenavirus entry, and its inhibition","volume":"4","author":"Nunberg","year":"2012","journal-title":"Viruses"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"25280","DOI":"10.1038\/SREP25280","article-title":"New hosts of the Lassa virus","volume":"6","author":"Olayemi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/J.TIM.2019.12.006","article-title":"The cap-snatching mechanism of Bunyaviruses","volume":"28","author":"Olschewski","year":"2020","journal-title":"Trends Microbiol."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1128\/jvi.00257-16","article-title":"Lassa virus cell entry via Dystroglycan involves an unusual pathway of macropinocytosis","volume":"90","author":"Oppliger","year":"2016","journal-title":"J. Virol."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"19036","DOI":"10.1073\/PNAS.1113643108\/-\/DCSUPPLEMENTAL\/PNAS.201113643SI.PDF","article-title":"RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses","volume":"108","author":"Panda","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1586\/ERI.12.117","article-title":"Current drug discovery strategies against arenavirus infections","volume":"10","author":"Pasquato","year":"2012","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-319-75474-1_3","article-title":"Cleavage of the glycoprotein of arenaviruses","volume":"47","author":"Pasquato","year":"2018","journal-title":"Activ. Viruses Host Proteases"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3201\/EID1510.090211","article-title":"Nosocomial outbreak of novel arenavirus infection, southern Africa","volume":"15","author":"Paweska","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1128\/JVI.02077-15","article-title":"The synthetic antiviral drug Arbidol inhibits globally prevalent pathogenic viruses","volume":"90","author":"P\u00e9cheur","year":"2016","journal-title":"J. Virol."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"105125","DOI":"10.1016\/J.BMCL.2021.127983","article-title":"Discovery of a novel highly potent broad-spectrum heterocyclic chemical series of arenavirus cell entry inhibitors","volume":"41","author":"Plewe","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"126620","DOI":"10.1016\/J.BMCL.2019.08.024","article-title":"SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors","volume":"29","author":"Plewe","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1357-2725(99)00070-9","article-title":"The transferrin receptor: role in health and disease","volume":"31","author":"Ponka","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4269\/AJTMH.1978.27.162","article-title":"Serological evidence of infection of Tacaribe virus and arboviruses in Trinidadian bats","volume":"27","author":"Price","year":"1978","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.VIROL.2017.09.028","article-title":"Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry","volume":"513","author":"Qiu","year":"2018","journal-title":"Virology"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/J.CHOM.2017.10.002","article-title":"NRP2 and CD63 are host factors for Lujo virus cell entry","volume":"22","author":"Raaben","year":"2017","journal-title":"Cell Host Microbe."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/NATURE05539","article-title":"Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses","volume":"446","author":"Radoshitzky","year":"2007","journal-title":"Nature"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/S00705-015-2418-Y\/TABLES\/6","article-title":"Past, present, and future of arenavirus taxonomy","volume":"160","author":"Radoshitzky","year":"2015","journal-title":"Arch. Virol."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"001891","DOI":"10.1099\/JGV.0.001891\/CITE\/REFWORKS","article-title":"ICTV virus taxonomy profile: Arenaviridae 2023","volume":"104","author":"Radoshitzky","year":"2023","journal-title":"J. Gen. Virol."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1073\/PNAS.0709254105","article-title":"Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses","volume":"105","author":"Radoshitzky","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/D41586-019-02840-W","article-title":"The advent and rise of monoclonal antibodies","volume":"575","author":"Rajewsky","year":"2019","journal-title":"Nature"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"11544","DOI":"10.1038\/NCOMMS11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nat. Commun."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1128\/JVI.02392-07","article-title":"Site 1 protease is required for proteolytic processing of the glycoproteins of the south American hemorrhagic fever viruses Junin, Machupo, and Guanarito","volume":"82","author":"Rojek","year":"2008","journal-title":"J. Virol."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.3390\/v4112766","article-title":"Immune responses and Lassa virus infection","volume":"4","author":"Russier","year":"2012","journal-title":"Viruses"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"e1001110","DOI":"10.1371\/JOURNAL.PPAT.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/VACCINES11030635","article-title":"Vaccine candidates against arenavirus infections","volume":"11","author":"Saito","year":"2023","journal-title":"Vaccine"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0010289","article-title":"Ribavarin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing","volume":"16","author":"Salam","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/14787210.2017.1305888","article-title":"Antiviral activity of cationic amphiphilic drugs","volume":"15","author":"Salata","year":"2017","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-642-56029-3_2","article-title":"Mammalian reservoirs of arenaviruses","volume":"262","author":"Salazar-Bravo","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/ANNUREV-VIROLOGY-101416-042001","article-title":"New World arenavirus biology","volume":"4","author":"Sarute","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"19497","DOI":"10.1073\/PNAS.1920551117\/-\/DCSUPPLEMENTAL","article-title":"CACNA1S haploinsufficiency confers resistance to New World arenavirus infection","volume":"117","author":"Sarute","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"e1009605","DOI":"10.1371\/JOURNAL.PPAT.1009605","article-title":"The board is set, the pieces are moving: modulation of New World arenavirus entry by host proteins","volume":"17","author":"Sarute","year":"2021","journal-title":"PLoS Pathog."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrd.2016.29","article-title":"Small molecules, big targets: drug discovery faces the protein-protein interaction challenge","volume":"15","author":"Scott","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/FCELL.2016.00091","article-title":"Regulation of muscle stem cell functions: A focus on the p38 MAPK signaling pathway","volume":"4","author":"Segal\u00e9s","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"e3233","DOI":"10.1371\/JOURNAL.PNTD.0003233","article-title":"Clinical features and patient management of Lujo hemorrhagic fever","volume":"8","author":"Sewlall","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1128\/jvi.00597-16","article-title":"Small-molecule fusion inhibitors bind the pH-sensing stable signal peptide-GP2 subunit Interface of the Lassa virus envelope glycoprotein","volume":"90","author":"Shankar","year":"2016","journal-title":"J. Virol."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/J.LFS.2018.02.033","article-title":"Axl inhibitors as novel cancer therapeutic agents","volume":"198","author":"Shen","year":"2018","journal-title":"Life Sci."},{"key":"ref159","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1292\/JVMS.12-0176","article-title":"Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein","volume":"74","author":"Shimojima","year":"2012","journal-title":"J. Vet. Med. Sci."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1128\/JVI.06451-11","article-title":"Identification of cell surface molecules involved in Dystroglycan-independent Lassa virus cell entry","volume":"86","author":"Shimojima","year":"2012","journal-title":"J. Virol."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"e1005276","DOI":"10.1371\/JOURNAL.PPAT.1005276","article-title":"Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection","volume":"11","author":"Sommerstein","year":"2015","journal-title":"PLoS Pathog."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/S11064-017-2223-Y","article-title":"Senicapoc: repurposing a drug to target microglia KCa3.1 in stroke","volume":"42","author":"Staal","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref163","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1021\/ACSINFECDIS.2C00416","article-title":"Sphingosine kinases promote Ebola virus infection and can be targeted to inhibit filoviruses, coronaviruses, and arenaviruses using late endocytic trafficking to enter cells","volume":"9","author":"Stewart","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"ref164","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/BLOOD-2002-05-1433","article-title":"ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice","volume":"101","author":"Stocker","year":"2003","journal-title":"Blood"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/J.ANTIVIRAL.2018.10.011","article-title":"Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever","volume":"160","author":"Tang","year":"2018","journal-title":"Antivir. Res."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/J.APSB.2020.02.014","article-title":"Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry","volume":"10","author":"Tang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1128\/JVI.00512-14","article-title":"Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus","volume":"88","author":"Tani","year":"2014","journal-title":"J. Virol."},{"key":"ref168","first-page":"218","article-title":"Mechanism of action of ribavirin in the treatment of chronic hepatitis C","volume":"3","author":"Te","year":"2007","journal-title":"Gastroenterol. Hepato."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"01744-18","DOI":"10.1128\/JVI.01744-18","article-title":"Identification of Clotrimazole derivatives as specific inhibitors of arenavirus fusion","volume":"93","author":"Torriani","year":"2019","journal-title":"J. Virol."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1128\/AAC.01668-15","article-title":"The clinically tested Gardos Channel inhibitor Senicapoc exhibits antimalarial activity","volume":"60","author":"Tubman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/TROPICALMED6020088","article-title":"Lymphocytic Choriomeningitis\u2014emerging trends of a neglected virus: A narrative review","volume":"6","author":"Vilibic-Cavlek","year":"2021","journal-title":"Trop. Med. Infect. Dis."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/NRI.2017.148","article-title":"Passive immunotherapy of viral infections: \u201csuper-antibodies\u201d enter the fray","volume":"18","author":"Walker","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"e00954-18","DOI":"10.1128\/JVI.00954-18","article-title":"Screening and identification of Lassa virus entry inhibitors from an FDA-approved drug library","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"e1007322","DOI":"10.1371\/JOURNAL.PPAT.1007322","article-title":"Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1","volume":"14","author":"Wang","year":"2018","journal-title":"PLoS Pathog."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"R891","DOI":"10.1016\/S0960-9822(00)00845-9","article-title":"Actin dynamics: assembly and disassembly of actin networks","volume":"10","author":"Wear","year":"2000","journal-title":"Curr. Biol."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.3748\/WJG.V23.I34.6252","article-title":"Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation","volume":"23","author":"Wei","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"105444","DOI":"10.1016\/J.ANTIVIRAL.2022.105444","article-title":"Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir","volume":"208","author":"Westover","year":"2022","journal-title":"Antivir. Res."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3201\/EID2403.171905","article-title":"New lineage of Lassa virus, Togo, 2016","volume":"24","author":"Whitmer","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1073\/PNAS.0909587107","article-title":"A broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.2147\/DDDT.S90580","article-title":"Maraviroc: a review of its use in HIV infection and beyond","volume":"9","author":"Woollard","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"ref181","first-page":"441","article-title":"Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-East Africa","volume":"55","author":"Wulff","year":"1977","journal-title":"Bull. World Health Organ."},{"key":"ref182","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1073\/PNAS.97.14.8151","article-title":"Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant","volume":"97","author":"Wulff","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref9001","year":"2018"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"10932","DOI":"10.1128\/jvi.01140-08","article-title":"pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors","volume":"82","author":"York","year":"2008","journal-title":"J. Virol."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1128\/jvi.00642-06","article-title":"Role of the stable signal peptide of Jun\u00edn arenavirus envelope glycoprotein in pH-dependent membrane fusion","volume":"80","author":"York","year":"2006","journal-title":"J. Virol."},{"key":"ref185","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1128\/jvi.02410-08","article-title":"Intersubunit interactions modulate pH-induced activation of membrane fusion by the Jun\u00edn virus envelope glycoprotein GPC","volume":"83","author":"York","year":"2009","journal-title":"J. Virol."},{"key":"ref186","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/v4102031","article-title":"Pathogenesis of lassa fever","volume":"4","author":"Yun","year":"2012","journal-title":"Viruses"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"e2023332118","DOI":"10.1073\/pnas.2023332118","article-title":"Therapy for argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody","volume":"118","author":"Zeitlin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1073\/pnas.1600996113","article-title":"Monoclonal antibody therapy for Junin virus infection","volume":"113","author":"Zeitlin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"104701","DOI":"10.1016\/J.ANTIVIRAL.2019.104701","article-title":"The antifungal isavuconazole inhibits the entry of Lassa virus by targeting the stable signal peptide-GP2 subunit interface of Lassa virus glycoprotein","volume":"174","author":"Zhang","year":"2020","journal-title":"Antivir. Res."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/J.ANTIVIRAL.2019.03.014","article-title":"Identification of a clinical compound losmapimod that blocks Lassa virus entry","volume":"167","author":"Zhang","year":"2019","journal-title":"Antivir. Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1382953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:52:37Z","timestamp":1712551957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1382953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":191,"alternative-id":["10.3389\/fmicb.2024.1382953"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1382953","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"article-number":"1382953"}}